Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-13-000678
Filing Date
2013-11-12
Accepted
2013-11-12 17:25:09
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q irsb1112form10q.htm 10-Q 336107
2 EXHIBIT 31.1 irsb1112form10qexh31_1.htm EX-31.1 10284
3 EXHIBIT 32.1 irsb1112form10qexh32_1.htm EX-32.1 4772
  Complete submission text file 0001554795-13-000678.txt   2769485

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE irsb-20130930.xml EX-101.INS 335427
5 XBRL SCHEMA FILE irsb-20130930.xsd EX-101.SCH 38355
6 XBRL CALCULATION FILE irsb-20130930_cal.xml EX-101.CAL 27979
7 XBRL DEFINITION FILE irsb-20130930_def.xml EX-101.DEF 49904
8 XBRL LABEL FILE irsb-20130930_lab.xml EX-101.LAB 239954
9 XBRL PRESENTATION FILE irsb-20130930_pre.xml EX-101.PRE 150364
Mailing Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054
Business Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054 408 867 2885
IRIS BIOTECHNOLOGIES INC (Filer) CIK: 0001396238 (see all company filings)

EIN.: 770506396 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53245 | Film No.: 131211497
SIC: 3841 Surgical & Medical Instruments & Apparatus